Highbridge Capital Management’s CVS Health CVS Stock Holding History

Highbridge Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,000	Closed	-$321K	–	565
2018 Q2	$321K	Buy	+5,000	New	+$330K	0.01%	690
2018 Q1	–	Sell	-150,600	Closed	-$10.9M	–	1271
2017 Q4	$10.9M	Buy	+150,600	New	+$10.9M	0.19%	142
2017 Q3	–	Sell	-8,500	Closed	-$683K	–	1568
2017 Q2	$683K	Sell	8,500 -22,100	-72%	-$1.75M	0.01%	664
2017 Q1	$2.4M	Buy	30,600 +17,300	+130%	+$1.38M	0.03%	422
2016 Q4	$1.05M	Buy	+13,300	New	+$1.08M	0.02%	527
2016 Q2	–	Sell	-6,600	Closed	-$685K	–	1455
2016 Q1	$685K	Sell	6,600 -3,800	-37%	-$369K	0.01%	862
2015 Q4	$1.02M	Sell	10,400 -6,600	-39%	-$646K	0.02%	748
2015 Q3	$1.64M	Buy	17,000 +10,200	+150%	+$1.07M	0.03%	607
2015 Q2	$713K	Sell	6,800 -10,500	-61%	-$1.07M	0.01%	839
2015 Q1	$1.78M	Buy	17,300 +5,600	+48%	+$567K	0.02%	567
2014 Q4	$1.13M	Buy	+11,700	New	+$1.03M	0.01%	611
2013 Q4	–	Sell	-13,500	Closed	-$766K	–	1106
2013 Q3	$766K	Buy	+13,500	New	+$804K	0.01%	748

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Highbridge Capital Management's CVS Position: Q3 2018 in Review

Highbridge Capital Management sold out of CVS Health (CVS) in Q3 2018, closing a stake of 4,251 shares — an estimated $274K sold.

Highbridge Capital Management first reported a position in CVS in Q2 2013 and held it in 12 quarters. The position peaked at $28.7M in Q3 2013. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

Highbridge Capital Management reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 4,251 CVS Health shares in Q3 2018, an estimated $274K.
Highbridge Capital Management first reported a position in CVS Health in Q2 2013 and held it in 12 quarters.
Highbridge Capital Management's CVS Health position peaked at $28.7M in Q3 2013.
1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.